Novartis Pharmaceuticals Launches the First App for Visually Impaired People for Use with Apple Watch and other Smart Watches

Novartis Pharmaceuticals announced the release of new features for its ViaOpta applications, and the extension for use with smart watches. The discreet, hands-free nature of using ViaOpta app with wearable devices, such as Apple Watch and Android Wear, provides users with an experience that seamlessly fits into their existing routines allowing those with visual impairments to navigate daily life with even greater ease.

Real-World Patient Benefits
"With the help of ViaOpta apps, people with impaired vision can do things such as walk to a nearby café, go to the pharmacy, and pick up their grandchildren at the kindergarten - helping to increase confidence and independence and maintaining discretion," explains Ian Banks, Chair, The European Forum Against Blindness (EFAB).

ViaOpta Nav is the first turn-by-turn navigation app available for a wearable device designed specifically for visually impaired people, providing voice guidance and vibration settings, which alert the user to upcoming intersections and landmarks. The users can ask for their exact position, add waypoints to a calculated route, and find nearby destinations or landmarks and save them as favorites. Users and their caretakers can also share and access a person's exact location.

Cutting-Edge Technology
"Novartis is committed to providing innovative solutions which go beyond medicine, like these apps for the visually impaired which benefit their daily quality of life," said David Epstein, Head of Pharma Division, Novartis Pharmaceuticals. "We are proud to contribute and play a role in making these simple and convenient tools like the ViaOpta Daily and ViaOpta Nav apps available around the world."

Globally, more than 285 million people live with vision impairment and blindness[1]. In order to reach as many of these people as possible, ViaOpta apps are now available in several languages with additional languages currently in development.

Highlights of Additional New Features for ViaOpta Apps:

  • ViaOpta Navigation:
    • Points of Interest Feature: The user will now be able to see Points of Interest nearby, divided into categories, find information on them and set a navigation to a specific point of interest. This also includes information on specific accessibility facilities around them, such as tactile pavement and crossings, traffic lights with sound (provided that this information is available on OpenStreetMaps for the area which the user is in)
    • Extended Map Coverage: The app coverage has been extended to the whole world, although coverage is less in rural areas
  • ViaOpta Daily:
    • New Object Recognizer Feature: Identifies objects in the user's field of vision when user points the camera of the device at an object
    • Addition of Scene Recognizer Feature: The user will be able to point the camera of the device at a desired direction or place and the voiceover will tell the user what is in front of them to help them navigate unfamiliar environments

Continuing a commitment to digital excellence
The smartphone versions of these patient apps won the prestigious European Excellence Award in 2014, the first year they were available. Downloaded over 6,700 times during the first two months after launch, these apps allow users to retain and in some case regain their independence and have been praised both for innovation and for real-life impact.

About Novartis
Novartis provides innovative healthcare solutions that address the evolving needs of patients and societies. Headquartered in Basel, Switzerland, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, eye care and cost-saving generic pharmaceuticals. Novartis is the only global company with leading positions in these areas. In 2014, the Group achieved net sales of USD 58.0 billion, while R&D throughout the Group amounted to approximately USD 9.9 billion (USD 9.6 billion excluding impairment and amortization charges). Novartis Group companies employ approximately 120,000 full-time-equivalent associates. Novartis products are available in more than 180 countries around the world.

1. International Agency for the Prevention of Blindness (IAPB), WHO Facts Blindness and Visual Impairment: Global Facts. http://www.iapb.org/vision-2020/global-facts [Accessed June 1, 2015]

iPhone and Apple Watch are trademarks of Apple Inc., registered in the US and other countries.

Most Popular Now

New App may Help Caregivers of People Ge…

A new study by investigators from Mass General Brigham showed that a new app they created can help improve the quality of life for caregivers of patients undergoing bone marrow...

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

New AI Transforms Radiology with Speed, …

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

New Research Finds Specific Learning Str…

If data used to train artificial intelligence models for medical applications, such as hospitals across the Greater Toronto Area, differs from the real-world data, it could lead to patient harm...

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

Patients say "Yes..ish" to the…

As artificial intelligence (AI) continues to be integrated in healthcare, a new multinational study involving Aarhus University sheds light on how dental patients really feel about its growing role in...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

'AI Scientist' Suggests Combin…

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs - used to treat conditions such as high cholesterol and alcohol dependence...

Brains vs. Bytes: Study Compares Diagnos…

A University of Maine study compared how well artificial intelligence (AI) models and human clinicians handled complex or sensitive medical cases. The study published in the Journal of Health Organization...

Start-ups in the Spotlight at MEDICA 202…

17 - 20 November 2025, Düsseldorf, Germany. MEDICA, the leading international trade fair and platform for healthcare innovations, will once again confirm its position as the world's number one hotspot for...